Skip to main content
European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Weight Maintenance by AgRP neurons

Descrizione del progetto

La base neuronale della gestione del peso

Riacquistare peso dopo una dieta è un fenomeno diffuso, noto come effetto yo-yo. Pertanto, comprendere i meccanismi responsabili del mantenimento della perdita di peso è importante, specialmente per il trattamento dell’obesità. Il progetto Yoyo-LepReSens, finanziato dall’UE, si concentrerà sui meccanismi epigenetici alla base del riacquisto di peso a causa della sovralimentazione. Gli scienziati studieranno l’epigenetica di un sottoinsieme specifico di neuroni nell’ipotalamo e decifreranno il modo in cui questi sono coinvolti nella gestione del peso. Il progetto approfondirà inoltre la comparsa della resistenza all’ormone leptina, noto per il ruolo nella regolazione del senso di sazietà. I risultati della ricerca costituiranno la base per la progettazione di interventi innovativi contro l’obesità.

Obiettivo

Obesity and its comorbid sequelae are major health burdens across European nations. Many citizens would greatly benefit from permanent weight loss, but only a few succeed. They rather suffer from weight regain after dieting, often referred to as Yoyo effect. Delineating the largely unexplored, CNS-driven molecular events that impede sustainable weight loss and drive the Yoyo effect is a prerequisite for future therapies, and a major goal of my proposal.
Recently, my lab demonstrated unprecedented weight loss in diet-induced obese mice treated with the plant-derived leptin sensitizer celastrol. Our data suggested breakthrough potential for therapeutic anti-obesity strategies built upon leptin re-sensitization, and pointed towards a key role for orexigenic circuitry and AgRP neurons residing in the hypothalamic arcuate nucleus. As 1st objective, we will 1) establish if leptin resistance originates in AgRP neurons, 2) delineate the molecular underpinnings of leptin resistance and leptin resensitization in AgRP neurons, 3) verify novel drug-able leptin signalling components in murine and human iPSC-derived cells and 4) identify leptin sensitizing weight loss drugs.
AgRP neurons will also be in the focus of my 2nd objective that targets epigenetic mechanisms of Yoyo dieting. Building upon our own data on epigenetic mechanisms that drive weight re-gain through hyperphagia, we will 1) establish if an epigenetic memory for obesity in AgRP neurons exists, 2) explore by Crispr-Cas9-based trans-epigenetic modulation of AgRP neurons in mice whether resetting the epigenetic memory for obesity can prevent weight regain and 3) demonstrate the human relevance of our new weight regulatory genes in post-mortem human hypothalami of lean, obese or type 2 diabetic donors.
Overall, my proposal will establish hypothalamic AgRP neurons as crucial drivers for leptin resistance and Yoyo dieting. My translational aims are further providing the groundwork for future anti-obesity therapeutics.

Meccanismo di finanziamento

ERC-COG - Consolidator Grant

Istituzione ospitante

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Contribution nette de l'UE
€ 1 999 976,00
Indirizzo
INGOLSTADTER LANDSTRASSE 1
85764 Neuherberg
Germania

Mostra sulla mappa

Regione
Bayern Oberbayern München, Landkreis
Tipo di attività
Research Organisations
Collegamenti
Costo totale
€ 1 999 976,00

Beneficiari (1)